相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model
Iori Takigami et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
TNFα Cooperates with IFN-γ to Repress Bcl-xL Expression to Sensitize Metastatic Colon Carcinoma Cells to TRAIL-mediated Apoptosis
Feiyan Liu et al.
PLOS ONE (2011)
Antisense anti IGF-I cellular therapy of malignant tumours: Immune response in cancer patients
J. Trojan et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Cancer and Inflammation: Implications for Pharmacology and Therapeutics
F. Balkwill et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Sequence-specific targeting of IGF-I and IGF-IR genes by camptothecins
Kahina Oussedik et al.
FASEB JOURNAL (2010)
Rational Design of Immunostimulatory siRNAs
Michael P. Gantier et al.
MOLECULAR THERAPY (2010)
Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
Fernando Pastor et al.
NATURE (2010)
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
Aimee L. Jackson et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?
Terry J. Smith
PHARMACOLOGICAL REVIEWS (2010)
Transforming Growth Factor-β-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition
Cynthia C. T. Sprenger et al.
CLINICAL CANCER RESEARCH (2009)
The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer
Claudia Lanari et al.
ENDOCRINE-RELATED CANCER (2009)
Activation of Stat3 by Heregulin/ErbB-2 through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth
Cecilia J. Proietti et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer
John S. P. Yuen et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice
Mary Ann Warren et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
siRNA and Innate Immunity
Marjorie Robbins et al.
OLIGONUCLEOTIDES (2009)
Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
A. Gualberto et al.
ONCOGENE (2009)
Regulation of IGF-I function by proinflammatory cytokines: At the interface of immunology and endocrinology
Jason C. O'Connor et al.
CELLULAR IMMUNOLOGY (2008)
TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways
Martfn A. Rivas et al.
EXPERIMENTAL CELL RESEARCH (2008)
Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer
John S. P. Yuen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
The Role of Endocrine Insulin-Like Growth Factor-I and Insulin in Breast Cancer
Danielle Lann et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Deepali Sachdev et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs
A. H. Yeh et al.
ONCOGENE (2006)
Role of tumor necrosis factor-α and its receptors in human benign breast lesions and tumors (in situ and infiltrative)
Ignacio Garcia-Tunon et al.
CANCER SCIENCE (2006)
Regulation of apoptosis by insulin-like growth factor (IGF)-I
Ron Kooijman
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway
Roxana Schillaci et al.
JOURNAL OF IMMUNOLOGY (2006)
Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis
AM Khatib et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
The insulin-like growth factor-1 receptor as a target for cancer therapy
R Baserga
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
The role of tumor stroma in the interaction between tumor and immune system
T Blankenstein
CURRENT OPINION IN IMMUNOLOGY (2005)
Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer
MA Rochester et al.
CANCER GENE THERAPY (2005)
Direct evidence that toll-like receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognition
S Cornélie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Immunotherapeutic uses of CpG oligodeoxynucleotides
DM Klinman
NATURE REVIEWS IMMUNOLOGY (2004)
Priming of naive T cells inside tumors leads to eradication of established tumors
P Yu et al.
NATURE IMMUNOLOGY (2004)
Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity
M Salatino et al.
ONCOGENE (2004)
The igf-1 receptor in cancer biology
R Baserga et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Decreased expression of the insulin-like growth factor 1 receptor by ribozyme cleavage
LC Shaw et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Tumor necrosis factor or tumor promoting factor?
F Balkwill
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo
CL Chernicky et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2002)
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells
K Scotlandi et al.
CANCER GENE THERAPY (2002)
Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense
AA Samani et al.
HUMAN GENE THERAPY (2001)
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma
A Ly et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Regulation of insulin-like growth factor-I receptor gene expression by tumor necrosis factor-α, and interferon-γ
M Shalita-Chesner et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas
DW Andrews et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Administration of subtumor regression dosage of TNF-α to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule
Y Lu et al.
GENE THERAPY (2001)
Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells
ME Balañá et al.
ONCOGENE (2001)
Alterations in tumorigenicity of embryonal carcinoma cells by ICF-I triple-helix induced changes in immunogenicity and apoptosis
A Ly et al.
LIFE SCIENCES (2000)
Crucial role of TNF-α in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo
A Prévost-Blondel et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
